Covalon Technologies Ltd. (COV) - Total Assets

Latest as of September 2025: CA$36.12 Million CAD ≈ $26.13 Million USD

Based on the latest financial reports, Covalon Technologies Ltd. (COV) holds total assets worth CA$36.12 Million CAD (≈ $26.13 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Covalon Technologies Ltd. (COV) net assets for net asset value and shareholders' equity analysis.

Covalon Technologies Ltd. - Total Assets Trend (2005–2025)

This chart illustrates how Covalon Technologies Ltd.'s total assets have evolved over time, based on quarterly financial data.

Covalon Technologies Ltd. - Asset Composition Analysis

Current Asset Composition (September 2025)

Covalon Technologies Ltd.'s total assets of CA$36.12 Million consist of 87.3% current assets and 12.7% non-current assets.

Asset Category Amount (CAD) % of Total Assets
Cash & Equivalents CA$0.00 48.1%
Accounts Receivable CA$5.84 Million 16.2%
Inventory CA$7.40 Million 20.5%
Property, Plant & Equipment CA$0.00 0.0%
Intangible Assets CA$1.35 Million 3.7%
Goodwill CA$0.00 0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Covalon Technologies Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Covalon Technologies Ltd. market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Covalon Technologies Ltd.'s current assets represent 87.3% of total assets in 2025, an increase from 26.0% in 2005.
  • Cash Position: Cash and equivalents constituted 48.1% of total assets in 2025, up from 14.3% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2005.
  • Asset Diversification: The largest asset category is inventory at 20.5% of total assets.

Covalon Technologies Ltd. Competitors by Total Assets

Key competitors of Covalon Technologies Ltd. based on total assets are shown below.

Company Country Total Assets
Alcon AG
SW:ALC
Switzerland CHF31.53 Billion
iRay Technology Co Ltd
SHG:688301
China CN¥11.33 Billion
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
China CN¥2.42 Billion
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
USA $32.49 Million
Jiangsu Nanfang Medical
SHG:603880
China CN¥993.46 Million
SDI Ltd
AU:SDI
Australia AU$141.20 Million
MEDIMI AB AK
F:79T
Germany €1.70 Million
I.Ceram SA
PA:ALICR
France €3.91 Million

Covalon Technologies Ltd. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 8.36 7.27 0.63
Quick Ratio 6.40 5.34 0.30
Cash Ratio 0.00 0.00 0.00
Working Capital CA$27.76 Million CA$25.04 Million CA$-8.00 Million

Covalon Technologies Ltd. - Advanced Valuation Insights

This section examines the relationship between Covalon Technologies Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.45
Latest Market Cap to Assets Ratio 1.07
Asset Growth Rate (YoY) 13.6%
Total Assets CA$36.12 Million
Market Capitalization $38.48 Million USD

Valuation Analysis

Above Book Valuation: The market values Covalon Technologies Ltd.'s assets above their book value (1.07x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: Covalon Technologies Ltd.'s assets grew by 13.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Covalon Technologies Ltd. (2005–2025)

The table below shows the annual total assets of Covalon Technologies Ltd. from 2005 to 2025.

Year Total Assets Change
2025-09-30 CA$36.12 Million
≈ $26.13 Million
+13.57%
2024-09-30 CA$31.81 Million
≈ $23.01 Million
+27.73%
2023-09-30 CA$24.90 Million
≈ $18.01 Million
-18.03%
2022-09-30 CA$30.38 Million
≈ $21.98 Million
-25.14%
2021-09-30 CA$40.58 Million
≈ $29.36 Million
+16.96%
2020-09-30 CA$34.70 Million
≈ $25.10 Million
-12.40%
2019-09-30 CA$39.61 Million
≈ $28.65 Million
+100.97%
2018-09-30 CA$19.71 Million
≈ $14.26 Million
+64.68%
2017-09-30 CA$11.97 Million
≈ $8.66 Million
+84.43%
2016-09-30 CA$6.49 Million
≈ $4.69 Million
-14.96%
2015-09-30 CA$7.63 Million
≈ $5.52 Million
-4.15%
2014-09-30 CA$7.96 Million
≈ $5.76 Million
+40.41%
2013-09-30 CA$5.67 Million
≈ $4.10 Million
-4.92%
2012-09-30 CA$5.96 Million
≈ $4.31 Million
-36.03%
2011-09-30 CA$9.32 Million
≈ $6.74 Million
-9.67%
2010-09-30 CA$10.32 Million
≈ $7.47 Million
-19.80%
2009-09-30 CA$12.87 Million
≈ $9.31 Million
-25.59%
2008-09-30 CA$17.29 Million
≈ $12.51 Million
-14.58%
2007-09-30 CA$20.24 Million
≈ $14.64 Million
+130.22%
2006-09-30 CA$8.79 Million
≈ $6.36 Million
+95.39%
2005-09-30 CA$4.50 Million
≈ $3.26 Million
--

About Covalon Technologies Ltd.

V:COV Canada Medical Instruments & Supplies
Market Cap
$38.48 Million
CA$53.19 Million CAD
Market Cap Rank
#22821 Global
#832 in Canada
Share Price
CA$1.94
Change (1 day)
+2.65%
52-Week Range
CA$1.56 - CA$2.88
All Time High
CA$9.18
About

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more